Trial site
University of Michigan Medical Center
- 11running trials
- 13closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Sarcoma5 trials
- Childhood cancers4 trials
- Coronary artery disease2 trials
- Heart failure2 trials
- Melanoma2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Aortic aneurysm1 trial
- Aplastic anaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- and 18 more
- Phase
- Phase 25 trials
- Phase 34 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Completed10 trials
- Active, not recruiting7 trials
- Recruiting4 trials
- Terminated3 trials
- Lead sponsor
- Abbott Medical Devices3 trials
- USWM CT, LLC2 trials
- Albert Einstein Healthcare Network1 trial
- Amgen1 trial
- Anagram Therapeutics, Inc.1 trial
- and 16 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD1 recruiting
- Haemophilia1 recruiting
- Heart failure1 recruiting
- Melanoma1 recruiting
- Nephrotic syndrome1 recruiting
Closed trials
Completed
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
Completed
Completed
Completed
Terminated
Completed
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis
Completed
Completed
Completed
Terminated
Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma
Completed
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026